147 related articles for article (PubMed ID: 38389278)
1. Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers.
Corso G; Davis JL; Strong VE
J Surg Oncol; 2024 May; 129(6):1082-1088. PubMed ID: 38389278
[TBL] [Abstract][Full Text] [Related]
2. Cancer surveillance as an alternative to prophylactic total gastrectomy in hereditary diffuse gastric cancer: a prospective cohort study.
Asif B; Sarvestani AL; Gamble LA; Samaranayake SG; Famiglietti AL; Fasaye GA; Quezado M; Miettinen M; Korman L; Koh C; Heller T; Davis JL
Lancet Oncol; 2023 Apr; 24(4):383-391. PubMed ID: 36990610
[TBL] [Abstract][Full Text] [Related]
3. CDH1 (E-Cadherin) Mutation and Gastric Cancer: Genetics, Molecular Mechanisms and Guidelines for Management.
Shenoy S
Cancer Manag Res; 2019; 11():10477-10486. PubMed ID: 31853199
[TBL] [Abstract][Full Text] [Related]
4. Outcomes of Endoscopic Surveillance in Individuals With Genetic Predisposition to Hereditary Diffuse Gastric Cancer.
Jacobs MF; Dust H; Koeppe E; Wong S; Mulholland M; Choi EY; Appelman H; Stoffel EM
Gastroenterology; 2019 Jul; 157(1):87-96. PubMed ID: 30935944
[TBL] [Abstract][Full Text] [Related]
5. Indications for Total Gastrectomy in CDH1 Mutation Carriers and Outcomes of Risk-Reducing Minimally Invasive and Open Gastrectomies.
Vos EL; Salo-Mullen EE; Tang LH; Schattner M; Yoon SS; Gerdes H; Markowitz AJ; Mandelker D; Janjigian Y; Offitt K; Coit DG; Stadler ZK; Strong VE
JAMA Surg; 2020 Nov; 155(11):1050-1057. PubMed ID: 32997132
[TBL] [Abstract][Full Text] [Related]
6. Chromoendoscopy in Combination with Random Biopsies for Patients with Pathogenic CDH1 Mutations Undergoing Endoscopic Surveillance.
Ruf B; Roggia C; Schroeder C; Mattern S; Fend F; Klag T; Götz M
J Gastrointest Cancer; 2023 Jun; 54(2):520-527. PubMed ID: 35499650
[TBL] [Abstract][Full Text] [Related]
7. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
[TBL] [Abstract][Full Text] [Related]
8. Hereditary diffuse gastric cancer: implications of genetic testing for screening and prophylactic surgery.
Cisco RM; Ford JM; Norton JA
Cancer; 2008 Oct; 113(7 Suppl):1850-6. PubMed ID: 18798546
[TBL] [Abstract][Full Text] [Related]
9. E-cadherin germline mutation carriers: clinical management and genetic implications.
Corso G; Figueiredo J; Biffi R; Trentin C; Bonanni B; Feroce I; Serrano D; Cassano E; Annibale B; Melo S; Seruca R; De Lorenzi F; Ferrara F; Piagnerelli R; Roviello F; Galimberti V
Cancer Metastasis Rev; 2014 Dec; 33(4):1081-94. PubMed ID: 25332147
[TBL] [Abstract][Full Text] [Related]
10. Combining clinical and molecular characterization of CDH1: a multidisciplinary approach to reclassification of a splicing variant.
Fillman C; Anantharajah A; Marmelstein B; Dillon M; Horton C; Peterson C; Lopez J; Tondon R; Brannan T; Katona BW
Fam Cancer; 2023 Oct; 22(4):521-526. PubMed ID: 37540482
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic Prophylactic Total Gastrectomy for Hereditary Diffuse Gastric Cancer in
Ithurralde-Argerich J; Rosner L; Rizzolo M; Faerberg A; Puma R; Ferro D; Duque C; Kujaruk M; Cuenca-Abente F
J Laparoendosc Adv Surg Tech A; 2021 Jul; 31(7):729-737. PubMed ID: 34097461
[No Abstract] [Full Text] [Related]
12. Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers.
van der Post RS; Vogelaar IP; Carneiro F; Guilford P; Huntsman D; Hoogerbrugge N; Caldas C; Schreiber KE; Hardwick RH; Ausems MG; Bardram L; Benusiglio PR; Bisseling TM; Blair V; Bleiker E; Boussioutas A; Cats A; Coit D; DeGregorio L; Figueiredo J; Ford JM; Heijkoop E; Hermens R; Humar B; Kaurah P; Keller G; Lai J; Ligtenberg MJ; O'Donovan M; Oliveira C; Pinheiro H; Ragunath K; Rasenberg E; Richardson S; Roviello F; Schackert H; Seruca R; Taylor A; Ter Huurne A; Tischkowitz M; Joe ST; van Dijck B; van Grieken NC; van Hillegersberg R; van Sandick JW; Vehof R; van Krieken JH; Fitzgerald RC
J Med Genet; 2015 Jun; 52(6):361-74. PubMed ID: 25979631
[TBL] [Abstract][Full Text] [Related]
13. The role of endoscopy in the management of hereditary diffuse gastric cancer syndrome.
Kumar S; Long JM; Ginsberg GG; Katona BW
World J Gastroenterol; 2019 Jun; 25(23):2878-2886. PubMed ID: 31249446
[TBL] [Abstract][Full Text] [Related]
14. Case Series of 11
Lepage M; Uhrhammer N; Privat M; Ponelle-Chachuat F; Kossai M; Scanzi J; Ouedraogo ZG; Gay-Bellile M; Bidet Y; Cavaillé M
Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761816
[TBL] [Abstract][Full Text] [Related]
15. Identification of c.1531C>T Pathogenic Variant in the
Norero E; Alarcon MA; Hakkaart C; de Mayo T; Mellado C; Garrido M; Aguayo G; Lagos M; Torres J; Calvo A; Guilford P; Corvalan AH
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600923
[TBL] [Abstract][Full Text] [Related]
16. Early genetic counseling and detection of CDH1 mutation in asymptomatic carriers improves survival in hereditary diffuse gastric cancer.
Moslim MA; Heald B; Tu C; Burke CA; Walsh RM
Surgery; 2018 Oct; 164(4):754-759. PubMed ID: 30145018
[TBL] [Abstract][Full Text] [Related]
17. Decision-making and regret in patients with germline
Gamble LA; Grant RRC; Samaranayake SG; Fasaye GA; Koh C; Korman L; Asif B; Heller T; Hernandez JM; Blakely AM; Davis JL
J Med Genet; 2023 Mar; 60(3):241-246. PubMed ID: 35817563
[TBL] [Abstract][Full Text] [Related]
18. Panel testing reveals nonsense and missense CDH1 mutations in families without hereditary diffuse gastric cancer.
Huynh JM; Laukaitis CM
Mol Genet Genomic Med; 2016 Mar; 4(2):232-6. PubMed ID: 27064202
[TBL] [Abstract][Full Text] [Related]
19. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
